Insights

Strategic Market Position ReShape Lifesciences as a comprehensive weight management partner for physicians and clinics by highlighting the integrated portfolio of surgical, non-surgical, and digital care programs (Lap-Band, ReShape Vest, ReShapeCare) to expand clinic offerings and patient reach.

Clinical Expansion Leverage ongoing European trials for ReShape Vest and upcoming neuromodulation and diabetes-focused devices to identify research partnerships, contract manufacturing opportunities, and early-adopter clinical sites in major markets.

HealthTech Synergy Explore collaborations with AI, digital health platforms, and remote coaching ecosystems (as seen with Motion Informatics and ReShapeCare) to offer bundled solutions for remote patient monitoring, rehabilitation, and chronic disease management.

Financing Readiness Capitalize on the company’s funding momentum and NIH SBIR grant history to attract hospital systems and payers by emphasizing cost-effective weight management programs, insurance coverage potential, and outcomes-based pricing.

Global Reach Target international expansion by engaging European and U.S. health systems with scalable surgical and non-surgical weight loss solutions, while promoting education and surgeon events (e.g., Lap-Band Surgeon Summit) to drive adoption and referrals.

EnteroMedics Tech Stack

EnteroMedics uses 8 technology products and services including Cloudflare CDN, Shopify, Vue.js, and more. Explore EnteroMedics's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Shopify
    E-commerce
  • Vue.js
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Facebook
    Widgets

Media & News

EnteroMedics's Email Address Formats

EnteroMedics uses at least 2 format(s):
EnteroMedics Email FormatsExamplePercentage
FLast@enteromedics.comJDoe@enteromedics.com
95%
First.Last@enteromedics.comJohn.Doe@enteromedics.com
5%
FLast@reshapelifesciences.comJDoe@reshapelifesciences.com
76%
Last@reshapelifesciences.comDoe@reshapelifesciences.com
15%
First@reshapelifesciences.comJohn@reshapelifesciences.com
7%
FirstLast@reshapelifesciences.comJohnDoe@reshapelifesciences.com
2%

Frequently Asked Questions

What is EnteroMedics's phone number?

Minus sign iconPlus sign icon
You can contact EnteroMedics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is EnteroMedics's stock symbol?

Minus sign iconPlus sign icon
EnteroMedics is a publicly traded company; the company's stock symbol is RSLS.

What is EnteroMedics's official website and social media links?

Minus sign iconPlus sign icon
EnteroMedics's official website is reshapelifesciences.com and has social profiles on LinkedInCrunchbase.

How much revenue does EnteroMedics generate?

Minus sign iconPlus sign icon
As of July 2026, EnteroMedics's annual revenue is estimated to be $1M - $10M.

What is EnteroMedics's NAICS code?

Minus sign iconPlus sign icon
EnteroMedics's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does EnteroMedics have currently?

Minus sign iconPlus sign icon
As of July 2026, EnteroMedics has approximately 15 employees across 1 continents, including North America. Key team members include SVP And CFO: G. L.Senior Vice President Of Sales: N. A.Vp, Market Development And Reimbursement: M. S.. Explore EnteroMedics's employee directory with LeadIQ.

What industry does EnteroMedics belong to?

Minus sign iconPlus sign icon
EnteroMedics operates in the Medical Equipment Manufacturing industry.

What technology does EnteroMedics use?

Minus sign iconPlus sign icon
EnteroMedics's tech stack includes Cloudflare CDNShopifyVue.jsjQuery MigrateYoast SEOX-Content-Type-OptionsGoogle AnalyticsFacebook.

What is EnteroMedics's email format?

Minus sign iconPlus sign icon
EnteroMedics's email format typically follows the pattern of FLast@enteromedics.com. Find more EnteroMedics email formats with LeadIQ.

How much funding has EnteroMedics raised to date?

Minus sign iconPlus sign icon
As of July 2026, EnteroMedics has raised $161M in funding. The last funding round occurred on Oct 18, 2017 for $61M.

When was EnteroMedics founded?

Minus sign iconPlus sign icon
EnteroMedics was founded in 2002.
EnteroMedics logo

EnteroMedics

Medical Equipment ManufacturingCalifornia, United States11-50 Employees

EnteroMedics, operating under the ReShape Lifesciences brand, is a medical equipment manufacturer focused on obesity treatment across the treatment continuum. Its portfolio includes both surgical and non-surgical weight loss solutions, such as the Lap-Band program, the ReShape Vest, and the ReShapeCare program, with the latter offering a reimbursable, physician-directed virtual weight management service. The company aims to help patients manage obesity and related metabolic conditions by providing devices and programs that address appetite, satiety, and weight-loss support, while seeking to improve access to coordinated care through evidence-based approaches. Headquartered in San Clemente, California, the organization serves the medical community and patients through device-based therapies and supportive care programs that can be integrated into clinical practice. A notable ongoing development is clinical work around the ReShape Vest, an investigational device intended to mimic some effects of traditional bariatric surgery without permanent anatomical changes, currently in European trials.

Section iconCompany Overview

Phone number
Stock Symbol
RSLS
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2002
Employees
11-50

Section iconFunding & Financials

  • $161M

    EnteroMedics has raised a total of $161M of funding over 10 rounds. Their latest funding round was raised on Oct 18, 2017 in the amount of $61Mas a post_ipo_equity.

  • $1M - $10M

    EnteroMedics's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $161M

    EnteroMedics has raised a total of $161M of funding over 10 rounds. Their latest funding round was raised on Oct 18, 2017 in the amount of $61Mas a post_ipo_equity.

  • $1M - $10M

    EnteroMedics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.